Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway
Lixin Du(Longgang Central Hospital), Ya Li(Nanjing Institute of Geology and Paleontology), Yifei Xiao(Guangzhou University of Chinese Medicine), Ziyan Wang(Harbin Medical University), Chengxin Liu(Guangzhou University of Chinese Medicine), Huiling Lu(Hunan University of Traditional Chinese Medicine), Zhihua Guo(Hunan University of Traditional Chinese Medicine)
Cited by 17
Related Papers
The gut-brain axis involved in polystyrene nanoplastics-induced neurotoxicity via reprogramming the circadian rhythm-related pathways
|Journal of Hazardous Materials|2023|96
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
|Ageing Research Reviews|2024|69
Upregulation of microRNA‑206 induces apoptosis of vascular smooth muscle cells and decreases risk of atherosclerosis through modulating FOXP1
|Experimental and Therapeutic Medicine|2017|30
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
|Scientific Reports|2023|16